AZTR
Azitra, Inc.
Key Financials
Net Income
$-10955370
↓ 22.2%
Operating Income
$-10966665
↑ 0.2%
EPS (Diluted)
$-2.25
↑ 5.1%
Revenue
$0
↓ 100.0%
Total Assets
$5.0M
↓ 31.7%
Shareholders' Equity
$3.8M
↑ 72.8%
Cash & Equivalents
$2.1M
↓ 54.6%
Total Liabilities
$1.2M
↓ 26.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 3/23/2026 | View on SEC |
| 4 | 3/20/2026 | View on SEC |
| 8-K | 3/13/2026 | View on SEC |
| DEFA14A | 3/5/2026 | View on SEC |
| 8-K | 3/5/2026 | View on SEC |
| 8-K | 2/27/2026 | View on SEC |
| 10-K | 2/27/2026 | View on SEC |
| DEFA14A | 2/6/2026 | View on SEC |
| 8-K | 2/6/2026 | View on SEC |
| S-8 | 1/30/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | AZTR |
| Company Name | Azitra, Inc. |
| CIK | 1701478 |
| Sector | Pharmaceutical Preparations |
| Industry | Emerging growth company |
| Exchange | NYSE |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (203) 489-0183 |